CoChat
Sign Up
Cited by 131Gastric Cancer Management and OutcomesPancreatic and Hepatic Oncology ResearchColorectal Cancer Surgical Treatments

The DOI matches its Crossref record, with a small difference in title or year; 32 of the 33 references it cites were found in a registry or an index.

The Impact of Neural Invasion Severity in Gastrointestinal Malignancies: A Clinicopathological Study

Open access
Liebl, Florian, Demir, Ihsan Ekin, Mayer, Katharina, Schuster, Tibor, D'Haese, Jan G., Becker, Karen, Langer, Rupert, Bergmann, Frank, Wang, Kun, Rosenberg, Robert, Novotny, Alexander R., Feith, Marcus, Reim, Daniel, Friess, Helmut, Ceyhan, Güralp O.·2014·Annals of Surgery
DOI 10.1097/sla.0000000000000968
Open this paper in CoChat — free account

Abstract

In Brief Objectives: Because neural invasion (NI) is still inconsistently reported and not well characterized within gastrointestinal malignancies (GIMs), our aim was to determine the exact prevalence and severity of NI and to elucidate the true impact of NI on patient's prognosis. Background: The union internationale contre le cancer (UICC) recently added NI as a novel parameter in the current TNM classification. However, there are only a few existing studies with specific focus on NI, so that the distinct role of NI in GIMs is still uncertain. Materials and Methods: NI was characterized in approximately 16,000 hematoxylin and eosin tissue sections from 2050 patients with adenocarcinoma of the esophagogastric junction (AEG)-I-III, squamous cell carcinoma (SCC) of the esophagus, gastric cancer (GC), colon cancer (CC), rectal cancer (RC), cholangiocellular cancer (CCC), hepatocellular cancer (HCC), and pancreatic cancer (PC). NI prevalence and severity was determined and related to patient's prognosis and survival. Results: NI prevalence largely varied between HCC/6%, CC/28%, RC/34%, AEG-I/36% and AEG-II/36%, SCC/37%, GC/38%, CCC/58%, and AEG-III/65% to PC/100%. NI severity score was uppermost in PC (24.9 ± 1.9) and lowest in AEG-I (0.8 ± 0.3). Multivariable analyses including age, sex, TNM stage, and grading revealed that the prevalence of NI was significantly associated with diminished survival in AEG-II/III, GC, and RC. However, increasing NI severity impaired survival in AEG-II/III and PC only. Conclusions: NI prevalence and NI severity strongly vary within GIMs. Determination of NI severity in GIMs is a more precise tool than solely recording the presence of NI and revealed dismal prognostic impact on patients with AEG-II/III and PC. Evidently, NI is not a concomitant side feature in GIMs and, therefore, deserves special attention for improved patient stratification and individualized therapy after surgery. Neural invasion (NI) in gastrointestinal malignancies (GIMs) is not well characterized and its clinical impact is unclear. In this comprehensive analysis of various GIMs, we demonstrate that the prevalence and severity of NI considerably varies between GIM. In pancreatic cancer and adenocarcinomas of the esophageal junction (AEG)-II/III, NI severity emerges as a key prognostic parameter.

Overview

Integrity signals

Registry

Crossref · 10.1097/sla.0000000000000968

Cites

32 of 32 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 33 references

Cited by

Sorted by citations

See all 131

Related

Metadata

Authors
Liebl, F., Demir, I. E., Mayer, K., Schuster, T., D'Haese, J. G., Becker, K., Langer, R., Bergmann, F., Wang, K., Rosenberg, R., Novotny, A. R., Feith, M., Reim, D., Friess, H., & Ceyhan, G. O.
Affiliations
  • Heidelberg University (DE)
  • TUM Klinikum (DE)
  • Peking University Cancer Hospital (CN)
Corresponding author
  • Liebl, Florian
  • Mayer, Katharina
  • Rosenberg, Robert
  • Novotny, Alexander R.
  • Feith, Marcus
  • Reim, Daniel
  • Friess, Helmut
ORCID
Venue
Annals of Surgery
Publisher
Ovid Technologies (Wolters Kluwer Health)
Published
2014-11
Volume
260
Issue
5
Pages
900-908
ISSN
0003-4932 (ISSN-L)
DOI
10.1097/sla.0000000000000968
OpenAlex
W2051017687
Cited by
131
References
33
Citations by year
2026: 12 · 2025: 20 · 2024: 15 · 2023: 15 · 2022: 11 · 2021: 14 · 2020: 10 · 2019: 8 · 2018: 4 · 2017: 8 · 2016: 8 · 2015: 6
FWCI
5.87
Type
journal article
Language
en
Open access
Licence
other-oa
Locations
  • Annals of Surgery (publishedVersion)
  • PubMed (publishedVersion)
  • Bern Open Repository and Information System (University of Bern) (submittedVersion, other-oa)
  • mediaTUM – the media and publications repository of the Technical University Munich (Technical University Munich) (submittedVersion)
  • Open Access CRIS of the University of Bern
Topics
  • Health Sciences › Medicine › Oncology › Gastric Cancer Management and Outcomes
  • Health Sciences › Medicine › Oncology › Pancreatic and Hepatic Oncology Research
  • Health Sciences › Medicine › Oncology › Colorectal Cancer Surgical Treatments
Keywords
perineural invasion, gastrointestinal cancer, prognosis, survival, TNM classification, gastroesophageal junction adenocarcinoma, gastric cancer, rectal cancer, pancreatic cancer, cholangiocarcinoma, hepatocellular carcinoma, colon cancer, esophageal squamous cell carcinoma, patient stratification, postoperative care
MeSH terms
Aged, Aged, 80 and over, Female, Gastrointestinal Neoplasms, Humans, Male, Middle Aged, Neoplasm Invasiveness, Neoplasm Staging, Nerve Tissue, Severity of Illness Index, Prevalence, Survival Rate, Neoplasm Grading

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review